SD BIOTECHNOLOGIES operates in the Chemicals sector.
Legal name: SD BIOTECHNOLOGIES CO., LTD.
In fiscal year 2025, SD BIOTECHNOLOGIES (217480) reported revenue of 30.1 billion KRW, down 12.8% from 34.5 billion KRW a year earlier.
Operating profit was -6.3 billion KRW and net income was -7.5 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 54.8 billion KRW, with a P/B of 1.83.
These figures can be verified in the DART filing (receipt no. 20260316001636).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 30.1B | -6.3B | -7.5B |
| 2024 | 34.5B | -9.2B | -14.8B |
| 2023 | 46.9B | -13.7B | -6.0B |
| 2022 | 92.9B | -41.0B | -75.0B |
| 2021 | 124.7B | -34.8B | -45.1B |
Recent Filings
Share Consolidation Decision
Record Date Setting
Meeting Resolution (Extraordinary Meeting)
Checks
3 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-27 | Share Consolidation Decision |
| 2026-08-27 | Record Date Setting |
| 2026-08-27 | Meeting Resolution (Extraordinary Meeting) |
| 2026-08-12 | 기타시장안내 (개선기간 종료에 따른 상장폐지 여부 결정 안내) |
| 2026-08-07 | Semi-Annual Report (2026.06) |